Lim Siew-Na, Lee Shih-Tseng, Tsai Yu-Tai, Chen I-An, Tu Po-Hsun, Chen Jean-Lon, Chang Hsiu-Wen, Su Yu-Chin, Wu Tony
Section of Epilepsy, Department of Neurology, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC.
Chang Gung Med J. 2008 May-Jun;31(3):287-96.
Deep brain stimulation (DBS) has re-emerged as an alternative therapy for intractable epilepsy. In this study, we investigated the feasibility, efficacy and safety of long-term anterior thalamic nucleus (ATN) stimulation for intractable epilepsy.
In this open-label pilot study of electrical stimulation of the ATN, we investigated four cases of intractable epilepsy (one man with generalized seizure, and three woman with partial seizure and secondary generalization; age range, 18-45 years), with a follow up of 2 years. Under the indication of bilateral or nonlocalized epileptic foci, each patient underwent stereotactic implantation of a quadripolar stimulating electrode in the bilateral ATN, guided by single-unit microelectrode recording. The stimulator was turned on after a sham period of 2-4 weeks. Seizure frequency was monitored and compared with the pre-implantation baseline. Twenty-one similar cases reported in the literature during the past 20 years were reviewed.
Insertion into and stimulation through electrodes implanted in the ATN decreased seizure frequency, with a mean reduction rate of 49.6% in the current series. Two patients had seizure reductions of > or = 60%, with complete remission achieved in one patient. These findings were consistent with those in four other investigations of intractable epilepsy, which showed an overall rate of 45-55% in seizure reduction. One of our patients suffered a small frontal hemorrhage, and a second patient had extension erosion over the scalp; however, no resultant major or permanent neurological deficits were observed.
Based on our study results and literature review, it appears reasonable to conclude that long-term ATN stimulation is a safe and effective treatment for seizure reduction in patients with intractable epilepsy.
深部脑刺激(DBS)已再度成为治疗顽固性癫痫的一种替代疗法。在本研究中,我们调查了长期丘脑前核(ATN)刺激治疗顽固性癫痫的可行性、疗效和安全性。
在这项关于ATN电刺激的开放性试点研究中,我们调查了4例顽固性癫痫患者(1例全身性发作男性患者,3例部分性发作伴继发性全身性发作女性患者;年龄范围18 - 45岁),随访2年。在双侧或非局限性癫痫病灶的指征下,每位患者在单单位微电极记录引导下,于双侧ATN立体定向植入四极刺激电极。经过2 - 4周的假刺激期后开启刺激器。监测癫痫发作频率并与植入前基线进行比较。回顾了过去20年文献中报道的21例类似病例。
通过植入ATN的电极进行插入和刺激可降低癫痫发作频率,本系列研究中平均降低率为49.6%。2例患者癫痫发作减少≥60%,1例患者实现完全缓解。这些发现与其他四项关于顽固性癫痫的研究结果一致,后者显示癫痫发作减少的总体率为45 - 55%。我们的1例患者发生了少量额叶出血,另1例患者头皮出现扩展性糜烂;然而,未观察到由此导致的重大或永久性神经功能缺损。
基于我们的研究结果和文献综述,得出长期ATN刺激是治疗顽固性癫痫患者减少癫痫发作的一种安全有效方法这一结论似乎是合理的。